PRECISION BIOSCIENCES INC
DTIL · XNASCIK 1357874fmd_1SB8F41PZ50WHZPPMTS2GT5E8XManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2018 to Sep 30, 2026, 35 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 11 | 1,070 | 24 | 116 | 25 | 49 | 69 | 34 |
| Research and development | 45 | 82 | 98 | 115 | 46 | 53 | 60 | 54 |
| Total operating expenses | 59 | 109 | 134 | 155 | 87 | 92 | 95 | 86 |
| Operating income | (48) | (87) | (110) | (39) | (62) | (44) | (26) | (52) |
| Interest expense | – | 0 | – | 0 | 1 | 2 | 2 | 1 |
| Interest and investment income | 2 | 4 | 1 | 0 | – | – | – | – |
| Other non-operating income (expense) | 2 | (6) | 1 | 9 | (11) | 1 | 33 | 6 |
| Income before taxes | – | – | – | – | – | – | 7 | (46) |
| Income tax expense | – | – | 0 | – | – | – | 0 | 0 |
| Net income from continuing operations | – | – | – | – | (73) | (43) | 7 | (47) |
| Net income | (46) | (93) | (109) | (31) | (112) | (61) | 7 | (46) |